Potential treatments for epigenetic dysregulation in neurological diseases

Potential treatments for epigenetic dysregulation in neurological diseases

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliografiset tiedot
Päätekijä:	Zaman, Rubaiyat
Muut tekijät:	Sharmin, Sabrina
Aineistotyyppi:	Opinnäyte
Kieli:	English
Julkaistu:	Brac University 2024
Aiheet:	Epigenetics Methylation Parkinson’s disease Alzheimer’s disease Huntington’s disease Acetylation Nervous System Diseases Epigenesis
Linkit:	http://hdl.handle.net/10361/23157

Samankaltaisia teoksia

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
Tekijä: Mostofa, Golam
Julkaistu: (2022)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
Tekijä: Dey, Manashi
Julkaistu: (2024)

Role of epigenetics in the development of metabolic disorders: a review
Tekijä: Mita, Tanzia Mohsin
Julkaistu: (2024)

Role of circular RNA in neurological disease
Tekijä: Salsabil, Labiba
Julkaistu: (2024)

Gene editing for neurodegenerative diseases-A review
Tekijä: Sharna, Anika Islam
Julkaistu: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
Tekijä: Alim, Abdul
Julkaistu: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
Tekijä: Annee, Israt Jahan
Julkaistu: (2023)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
Tekijä: Afsana, Nourin
Julkaistu: (2022)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
Tekijä: Chowdhury, Sariya Uzrat
Julkaistu: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
Tekijä: Ferdous, Labiba
Julkaistu: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
Tekijä: Bakar, Osama Bin Abu
Julkaistu: (2024)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
Tekijä: Tabassum, Nadira
Julkaistu: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
Tekijä: Islam, Md. Irfath
Julkaistu: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
Tekijä: Shehab, Habibul Mohsin
Julkaistu: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
Tekijä: Afreen, Nuraia
Julkaistu: (2021)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
Tekijä: Karmaker, Swastika
Julkaistu: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
Tekijä: Key, Nasrin Sultana
Julkaistu: (2023)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
Tekijä: Tamanna, Mst. Taskia
Julkaistu: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
Tekijä: Tasneem, Sadia
Julkaistu: (2021)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
Tekijä: Ishrat, Nowshin
Julkaistu: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
Tekijä: Saha, Bithi Rani
Julkaistu: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
Tekijä: Chowdhury, Amal
Julkaistu: (2024)

A review on cardiovascular development and epigenetics
Tekijä: Srity, Nafisa Alam
Julkaistu: (2024)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
Tekijä: Hassan, Md. Muhtaz
Julkaistu: (2020)

Marine compounds in the treatment of Alzheimer’s disease
Tekijä: Parveen, Sanjana
Julkaistu: (2022)

Alzheimer's disease and marriage : an intimate account /
Tekijä: Wright, Lore K.
Julkaistu: (1993)

Review on: the mechanism and function of Glia in parkinson's disease
Tekijä: Abedin, Khondokar Mezbahul
Julkaistu: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
Tekijä: Tasin, Md Abtahi
Julkaistu: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
Tekijä: Aziz, Farhin
Julkaistu: (2019)

Infection and communicable diseases /
Tekijä: Brettle, Raymond Patrick
Julkaistu: (1984)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
Tekijä: Afra, Sumaiya
Julkaistu: (2022)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
Tekijä: Mahee, Sadique Abdal
Julkaistu: (2024)

Early detection of parkinson’s disease using image processing and artificial neural network
Tekijä: Rumman, Mosarrat, et al.
Julkaistu: (2018)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
Tekijä: Rawshan, A. E. Maisha
Julkaistu: (2022)

A study on less explored plants with potential neuroprotective activity against neurodegenerative diseases
Tekijä: Nayeem, Abdullah Al
Julkaistu: (2021)

Control of communicable diseases manual : an official report of the American Public Health Association /
Julkaistu: (1995)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
Tekijä: Islam, Md. Rakibul
Julkaistu: (2023)

Clinical Infectious Diseases

The Journal of Infectious Diseases

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
Tekijä: Halim, Rabea
Julkaistu: (2022)